Pancreatic Cyst Surveillance: Who, Why, How?
Lyndon LukAndrew M LowyKevin LiKathryn J FowlerZhen Jane WangIhab R KamelJoy LiauPublished in: Radiology (2023)
Pancreatic cystic lesions (PCLs) are widely prevalent and commonly encountered in abdominal radiology. Some PCLs can be definitively identified at imaging as benign subtypes or those with malignant potential, while others remain indeterminate. Notably, the degree of malignant potential and natural history of the most common subtype, branch-duct intraductal papillary mucinous neoplasms, are not clearly established. In the work-up of PCLs, patients may further be identified as high-risk individuals who are at elevated risk of pancreatic ductal adenocarcinoma due to familial and genetic factors. This review describes current PCL surveillance and management guidelines and highlights ongoing controversies and future directions to aid radiologists in their daily practice.
Keyphrases
- end stage renal disease
- public health
- artificial intelligence
- newly diagnosed
- ejection fraction
- primary care
- healthcare
- peritoneal dialysis
- high resolution
- prognostic factors
- genome wide
- physical activity
- early onset
- machine learning
- current status
- gene expression
- dna methylation
- copy number
- photodynamic therapy
- tissue engineering